Literature DB >> 20169670

Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy.

Stéphanie Motton1, Gilles Houvenaeghel, Martine Delannes, Denis Querleu, Marc Soulé-Tholy, Jean Hoff, Pierre Lèguevaque.   

Abstract

OBJECTIVES: The primary objective of this study was to compare disease-free survival (DFS) and overall survival (OS) of patients with and without completion surgery. The secondary objective was to compare DFS and OS of patients who had had systematic simple extrafascial hysterectomy or extended hysterectomy. The other objectives were to compare early and late complications with and without completion surgery and between the various surgical techniques.
METHODS: One hundred seventy-one patients with advanced cervical cancer were included in a retrospective, multicenter series.
RESULTS: The rate of pelvic control was 81.29% in our study after chemoradiotherapy, but histological residual cervical tumor persisted in nearly half of cases (49.71%). After a mean follow-up of 33 months, OS and DFS were not significantly higher in surgically treated patients, nor was the complication rate higher. Overall survival and DFS were not better after radical hysterectomy than after extrafascial hysterectomy. Statistically significant predictors of survival were clinical stage, tumor size, node extension, and residual tumor after chemoradiotherapy.
CONCLUSION: There is no consensus regarding the maximal residual tumor volume after chemoradiotherapy suitable for surgery as there is no reliable imaging yet. Therefore, extrafascial hysterectomy with bilateral pelvic lymphadenectomy seems as a reasonable option if there are histological factors suggesting poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20169670     DOI: 10.1111/igc.0b013e3181c9e385

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  14 in total

1.  The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.

Authors:  A L Valentini; M Miccò; B Gui; M Giuliani; E Rodolfino; A M Telesca; T Pasciuto; A Testa; M A Gambacorta; G Zannoni; V Rufini; A Giordano; V Valentini; G Scambia; R Manfredi
Journal:  Eur Radiol       Date:  2018-01-09       Impact factor: 5.315

2.  Adjuvant hysterectomy after radiochemotherapy for locally advanced cervical cancer.

Authors:  Peter Hass; Holm Eggemann; Serban Dan Costa; Atanas Ignatov
Journal:  Strahlenther Onkol       Date:  2017-06-28       Impact factor: 3.621

3.  The Role of Adjuvant Hysterectomy After Radiotherapy in Cervical Cancer.

Authors:  P Rema; S Suchetha; Aswin Kumar; Iqbal Ahmed
Journal:  Indian J Surg       Date:  2014-04-10       Impact factor: 0.656

4.  Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers.

Authors:  S Marnitz; C Köhler; A Rauer; A Schneider; V Budach; A Tsunoda; M Mangler
Journal:  Strahlenther Onkol       Date:  2013-07-27       Impact factor: 3.621

5.  Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.

Authors:  Gabriella Macchia; Savino Cilla; Francesco Deodato; Francesco Legge; Aida Di Stefano; Vito Chiantera; Giovanni Scambia; Vincenzo Valentini; Alessio G Morganti; Gabriella Ferrandina
Journal:  Br J Radiol       Date:  2015-09-21       Impact factor: 3.039

6.  Aspects of Therapy for Cervical Cancer in Germany 2012 - Results from a Survey of German Gynaecological Hospitals.

Authors:  M Mangler; N Zech; A Schneider; C Köhler; S Marnitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-03       Impact factor: 2.915

7.  Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma.

Authors:  Jie Yang; Keng Shen; Jinhui Wang; Jiaxin Yang; Dongyan Cao
Journal:  J Gynecol Oncol       Date:  2016-04-18       Impact factor: 4.401

8.  Clinical outcome observation of preoperative concurrent chemoradiotherapy/radiotherapy alone in 174 Chinese patients with local advanced cervical carcinoma.

Authors:  Li-Chun Wei; Ning Wang; Mei Shi; Jun-Yue Liu; Jian-Ping Li; Ying Zhang; Yan-Hong Huang; Xia Li; Yan Chen
Journal:  Onco Targets Ther       Date:  2013-02-07       Impact factor: 4.147

9.  Comparison of concurrent chemoradiotherapy followed by radical surgery and high-dose-rate intracavitary brachytherapy: a retrospective study of 240 patients with FIGO stage IIB cervical carcinoma.

Authors:  Ning Wang; Wei-Wei Li; Jian-Ping Li; Juan-Yue Liu; Yong-Chun Zhou; Ying Zhang; Jing Hu; Yan-Hong Huang; Yan Chen; Li-Chun Wei; Mei Shi
Journal:  Onco Targets Ther       Date:  2014-01-06       Impact factor: 4.147

10.  Concurrent chemoradiotherapy for cervical cancer: background including evidence-based data, pitfalls of the data, limitation of treatment in certain groups.

Authors:  Yukiharu Todo; Hidemichi Watari
Journal:  Chin J Cancer Res       Date:  2016-04       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.